A Randomized Controlled Trial to Assess Sunscreen Application and Beta Carotene Supplementation in the Prevention of Solar Keratoses
- 1 April 2003
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (4), 451-455
- https://doi.org/10.1001/archderm.139.4.451
Abstract
Background Solar keratoses (SKs) are among the strongest determinants of skin cancer, but little is known about the success of measures to control these common skin tumors. Objective To determine whether daily sunscreen application and/or beta carotene supplementation retards the rate of occurrence of SKs in adults in the medium term. Design Randomized controlled trial conducted between February 1992 and August 1996. Setting General community of the subtropical township of Nambour, Australia (latitude, 26° south). Participants A total of 1621 adults aged 25 to 74 years. Interventions Participants were randomized to daily use of sunscreen (application of a high-protection sunscreen to their head, neck, arms, and hands every morning) or application of sunscreen at their usual discretionary rate. They were also randomly assigned to take either one 30-mg tablet of beta carotene or one placebo tablet each day. Main Outcome Measure Change in the prevalent number of SKs in the intervention group relative to change in the control group. Results The ratio of SK counts in 1994 relative to 1992 was lower in people randomized to daily sunscreen use (1.20; 95% confidence interval, 1.04-1.39) than in those randomized to discretionary sunscreen use (1.57; 95% confidence interval, 1.35-1.84). This 24% reduction is equivalent to the prevention of an average of 1 additional SK per person over that time. A reduction in the rate of change of SK prevalence was also seen in the sunscreen intervention group relative to the discretionary sunscreen group between 1994 and 1996, but it was not significant. No effect on the rate of change of prevalent SK counts was seen among those taking beta carotene supplements relative to those taking placebo tablets. Conclusions Daily application of sunscreen retarded the rate of SK acquisition among adults in a subtropical environment, while a beta carotene supplementation of 30 mg/d had no influence on the occurrence of SKs.Keywords
This publication has 11 references indexed in Scilit:
- High Incidence and Regression Rates of Solar Keratoses in a Queensland CommunityJournal of Investigative Dermatology, 2000
- Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985–1995: Are primary prevention programs starting to have an effect?International Journal of Cancer, 1998
- Skin Cancer in a Subtropical Australian Population: Incidence and Lack of Association with OccupationAmerican Journal of Epidemiology, 1996
- The nambour skin cancer and actinic eye disease prevention trial: Design and baseline characteristics of participantsControlled Clinical Trials, 1994
- Effect of a Low-Fat Diet on the Incidence of Actinic KeratosisNew England Journal of Medicine, 1994
- Nonmelanoma skin cancer in the United States: IncidenceJournal of the American Academy of Dermatology, 1994
- Reduction of Solar Keratoses by Regular Sunscreen UseNew England Journal of Medicine, 1993
- MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMAThe Lancet, 1988
- CAROTENOIDS AFFECT DEVELOPMENT OF UV‐B INDUCED SKIN CANCERPhotochemistry and Photobiology, 1987
- Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyriaJAMA, 1974